Evidence mapPaperPMID 39364567Full record

ReviewJournal of comparative effectiveness research2024

Use of transportability methods for real-world evidence generation: a review of current applications.

Natalie S Levy, Patrick J Arena, Thomas Jemielita, Shahrul Mt-Isa, Shane McElwee, David Lenis, Ulka B Campbell, Ashley Jaksa, Gleicy M Hair

Abstract readReview
In one paragraph

Review in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Actions for stakeholders to develop better real-world evidence for HTA bodies/payers decision making.International journal of technology assessment in health care · 2025
    Article
  7. Real-world evidence: state-of-the-art and future perspectives.Journal of comparative effectiveness research · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natalie S LevyScientific Research & Strategy, Aetion, Inc., New York, NY 10001, USA.ORCID 0000-0002-6828-8237
Patrick J ArenaScientific Research & Strategy, Aetion, Inc., Boston, MA 02109, USA.ORCID 0000-0003-3024-771X
Thomas JemielitaBiostatistics & Research Decision Sciences (BARDS), Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ 07065, USA.ORCID 0000-0001-7788-1828
Shahrul Mt-IsaBiostatistics & Research Decision Sciences (BARDS), MSD Innovation & Development Hub GmbH, Merck Sharp & Dohme, Zürich, 8058, Switzerland.ORCID 0000-0002-7163-8402
Shane McElweeScience & Delivery, Aetion, Inc., New York, NY10001, USA.ORCID 0000-0003-3694-441X
David LenisScientific Research & Strategy, Aetion, Inc., New York, NY 10001, USA.ORCID 0000-0001-8697-1737
Ulka B CampbellScientific Research & Strategy, Aetion, Inc., New York, NY 10001, USA.ORCID 0000-0002-3503-8178
Ashley JaksaScientific Research & Strategy, Aetion, Inc., Boston, MA 02109, USA.ORCID 0000-0003-3571-3345
Gleicy M HairCenter for Observational & Real-World Evidence (CORE), Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ 07065, USA.ORCID 0000-0002-9106-7424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Comparative Effectiveness ResearchHumansResearch Designreal-world datareal-world evidencetransportability

Identifiers

PMID39364567
PMCPMC11542082

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.